Description:
|
(1) - Pharmaceutical preparations for treating central nervous system diseases or disorders
(2) - Pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, sleep disorders, smoking habits or addictions, obesity, eating disorders, cognitive disorders, depression, ADHD, schizophrenia, anxiety, pain, migraine and substance abuse or respiratory system diseases or disorders, Parkinson's Disease OFF hypomobility episodes, binge eating disorders, pharmaceutical preparations for the treatment of Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip, therapeutic pharmaceutical preparations to manage Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip, pharmaceutical preparations for the treatment of Parkinson's Disease and therapeutic pharmaceutical preparations for the treatment of Parkinson's Disease
(3) - Pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, sleep disorders, smoking habits or addictions, obesity, eating disorders, cognitive disorders, depression, ADHD, schizophrenia, anxiety, pain, migraine and substance abuse or respiratory system diseases or disorders, Parkinson's Disease OFF hypomobility episodes, binge eating disorders, pharmaceutical preparations for the treatment of Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip, therapeutic pharmaceutical preparations to manage Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip, pharmaceutical preparations for the treatment of Parkinson's Disease and therapeutic pharmaceutical preparations for the treatment of Parkinson's Disease
(4) - Pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular mobility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, sleep disorders, smoking habits or addictions, obesity, eating disorders, cognitive disorders, depression, ADHD, schizophrenia, anxiety, pain, migraine and substance abuse or respiratory system diseases or disorders, Parkinson's Disease OFF hypomobility episodes, binge eating disorders, pharmaceutical preparations for the treatment of Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip, therapeutic pharmaceutical preparations to manage Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip, pharmaceutical preparations for the treatment of Parkinson's Disease and therapeutic pharmaceutical preparations for the treatment of Parkinson's Disease
|